
Hanmi | Hanmi Pharmaceutical's official site
Dec 23, 2024 · Hanmi Pharmaceutical is a leading biopharma company in Korea that focuses on providing outstanding medicines developed in-house to medical professionals and patients, as …
Hanmi Pharm - Wikipedia
Hanmi Pharm Co., Ltd. (Korean: 한미약품 주식회사; Hanja: 韓美藥品 株式會社) is a South Korean pharmaceutical company that is headquartered in Seoul. [1] Hanmi was founded in 1973 by …
Company Introduction | Hanmi Pharmaceutical
Hanmi Pharmaceutical, boasting the largest pipeline of innovative new drugs in Korea, invites you to explore our overview, vision, values, and corporate identity (CI).
Innovative R&D Pipeline | Hanmi Pharmaceutical
Hanmi Pharmaceutical is striving to develop an innovative new drug pipeline to treat anticancer, metabolic syndrome, and rare diseases.
Hanmi Science announces reorganization ‘to establish mid- and …
19 hours ago · “The Hanmi Group is on the verge of a new beginning,” Kim said in the message, titled “Hanmi, a powerhouse in new drug development, faces time to leap forward as a global …
Hanmi’s Kim Jae-kyo Targets Global Growth Through Drug …
1 day ago · In the message, Kim emphasized the group’s goal of becoming a global pharmaceutical leader through innovative drug development. “Hanmi Group stands on the …
Hanmi Pharmaceutical’s ‘Gugutams’ to be Launched in
1 day ago · Hanmi Pharmaceutical is an R&D-focused pharmaceutical company committed to developing globally innovative therapies in areas of high unmet medical needs such as …
Hanmi Pharmaceutical aims for ₩5 tril. revenue by 2033 with …
Mar 6, 2025 · Hanmi Pharmaceutical has unveiled its corporate value enhancement plan, aiming to reach 5 trillion won ($3.46 billion) in sales by 2033. The company plans to maintain its R&D …
Hanmi seeks to gain on Wegovy with its own weight-loss drug
Jan 16, 2025 · SAN FRANCISCO — Hanmi Pharmaceutical aims to disrupt the obesity drug market currently led by Eli Lilly and Novo Nordisk with its own diverse range of weight-loss …
Hanmi Pharmaceutical's 'Gugutams' to be Launched in Mexico …
1 day ago · Hanmi Pharmaceutical's combination therapy for Obstructive Prostatic Growth (OPG) caused by Benign Prostatic Hyperplasia (BPH) and Erectile Dysfunction (ED), Gugutams, is …